List view / Grid view

IM Therapeutics

Filter the results

 

article

A new small molecule drug discovery and development platform for HLA-associated autoimmune diseases

23 April 2021 | By ,

In the arsenal of approved small molecule drugs, effective, genetically-targeted therapies for the treatment of autoimmune diseases are conspicuously scarce. ImmunoMolecular Therapeutics (IM Therapeutics) has developed a paradigm for the discovery and development of new molecular entities as a broad platform for blocking genetic targets that confer risk of disease development…